Global Continuous Bioprocessing Market
Continuous Bioprocessing Market Forecast to Surge at 22.4% CAGR, Driven by Rising Biopharmaceutical Demand and Adoption by CDMOs/CMOs
December 22, 2023 04:48 ET | Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation...
22157.jpg
Bispecific Antibody Competitive Landscape Report Unveils Comprehensive Insights on Therapeutics Assessment and Growth Dynamics in the Global Market
December 21, 2023 09:48 ET | Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Bispecific antibody - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering. Amidst rapid advancements in the...
22157.jpg
Global Continuous Bioprocessing Market 2024-2033: Comprehensive Analysis of Applications, Products, and Innovations
December 21, 2023 04:38 ET | Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Continuous Bioprocessing Market: Focus on Application, Product, Process, End Users, Region, and Competitive Landscape - Analysis and Forecast,...
22157.jpg
Bioreactors Market Forecasts to 2033: Robust Growth, Demand for Single-use Technologies and Regional Insights
December 19, 2023 04:48 ET | Research and Markets
Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Bioreactors Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global bioreactors market is poised for...
22157.jpg
Global Claudin 18.2 Targeted Therapy Research Report 2023-2028: Milestone Approval - Zolbetuximab's FDA Approval Paves the Way as the First CLDN18.2-Targeted Drug
December 15, 2023 05:18 ET | Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
U.S. Neurologists Ea
U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement
December 13, 2023 14:03 ET | Spherix Global Insights
Exton, PA, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Several clinical trials are underway for Bruton’s tyrosine kinase inhibitors (BTKi) targeting relapsing and progressive multiple sclerosis (RMS/PPMS)....
22157.jpg
SIMPONI Emerging Drug Insights and Market Forecasts to 2032
December 13, 2023 04:08 ET | Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "SIMPONI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Bertilimumab Emerging Drug Insight and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
December 07, 2023 09:58 ET | Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "Bertilimumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
SOLIRIS Drug Insight and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
December 07, 2023 09:43 ET | Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "SOLIRIS Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Research Nester Logo.jpg
Microbial Fermentation Technology Market revenue to hit USD 63 Billion by 2036, says Research Nester
December 06, 2023 06:00 ET | Research Nester
New York , Dec. 06, 2023 (GLOBE NEWSWIRE) -- The global microbial fermentation technology market size is expected to expand at 6% CAGR from 2024 to 2036. The market is anticipated to garner a...